« FDA Approvals - Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA | Main | Novartis Consumer Health Conducts Nationwide Voluntary Recall of Triaminic Vapor »

FDA Approvals - Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with


Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets with 180-Day Exclusivity (PR Newswire via Yahoo! Finance)
Ranbaxy Pharmaceuticals Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , announced today that the company has received approval from the U.S. Food and Drug Administration to manufacture and market Simvastatin Tablets USP, 80mg with 180-day exclusivity in the U.S.

Ranbaxy Receives FDA Approval to Market Simvastatin 80mg Tablets With 180-Day Exclusivity (RedNova)
PRINCETON, N.J., June 23 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that the company has received approval from the U.S.
 

©2006 FDA-News.com. All rights reserved.